María J. Crespo to Disease Progression
This is a "connection" page, showing publications María J. Crespo has written about Disease Progression.
Connection Strength
0.328
-
Crespo MJ, Cangiano JL, Altieri PI, Escobales N. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters. J Cardiovasc Pharmacol. 2012 Jun; 59(6):547-52.
Score: 0.091
-
Crespo MJ, Cruz N, Altieri PI, Escobales N. Chronic treatment with N-acetylcysteine improves cardiac function but does not prevent progression of cardiomyopathy in Syrian cardiomyopathic hamsters. J Cardiovasc Pharmacol Ther. 2011 Jun; 16(2):197-204.
Score: 0.082
-
Crespo MJ, Cruz N, Altieri PI, Escobales N. Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamster. J Cardiovasc Pharmacol Ther. 2008 Sep; 13(3):199-206.
Score: 0.069
-
Crespo MJ, Altieri PI, Escobales N. Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamsters. Vascul Pharmacol. 2006 Apr; 44(4):247-52.
Score: 0.059
-
Altieri PI, Marcial JM, Banchs HL, Escobales N, Crespo M, Gonz?lez W. Coronary levels of angiotensin-II and endothelin-I in diabetic patients with and without coronary artery disease. Bol Asoc Med P R. 2015 Jan-Mar; 107(1):5-7.
Score: 0.027